Application of size exclusion chromatography in the development and characterization of nanoparticulate drug delivery systems

Journal of Liquid Chromatography and Related Technologies

Volumn 30, Issue 17, 2007, Pages 2489-2514

  Otto, Daniel P ^a   Vosloo, Hermanus C M ^a   De Villiers, Melgardt M ^b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Drug delivery; Nanoparticulate; Quality control; Size exclusion chromatography

Indexed keywords

DRUG DELIVERY; NANOSTRUCTURES; QUALITY CONTROL; STANDARDS;

NANOSIZED DELIVERY SYSTEMS; NANOSYSTEM CHARACTERIZATION;

SIZE EXCLUSION CHROMATOGRAPHY;

CHITOSAN; DRUG CARRIER; EXCIPIENT; GELATIN; NANOPARTICLE; PACLITAXEL; POLY[N (2 HYDROXYPROPYL)METHACRYLAMIDE]; POLYLACTIC ACID; POLYMER; TRASTUZUMAB;

BIODEGRADATION; DRUG CONFORMATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG STABILITY; GEL PERMEATION CHROMATOGRAPHY; MOLECULAR WEIGHT; NANOTECHNOLOGY; PARTICLE SIZE; PROCESS OPTIMIZATION; QUALITY CONTROL; REVIEW;

EID: 34547877611     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070701540076     Document Type: Review

References (55)

1. Wehr, T.; Rodriguez-Diaz, R. Use of size exclusion chromatography in biopharmaceutical development. In Analytical Techniques for Biopharmaceutical Development; Rodriguez-Diaz, R., Wehr, T., and Tuck, S., Eds.; Marcel Dekker: New York, 2005, 95-112.
2. The United States Pharmacopeia XXIX; United States Pharmacopeial Convention Inc.: Rockville MD, 2006.
3. Barth, H.; Boyes, B.E.; Jackson, C. Size exclusion chromatography and related separation techniques. Anal. Chem. 1998, 70 (12), 251R-278R.
4. National Nanotechnology Initiative. What is Nanotechnology? 〈http://www. nano.gov/html/facts/whatIsNano.html.〉 Accessed: 01.08.2007.
5. Shah, P. Use of nanotechnologies for drug delivery. MRS Bull. 2006, 31 (11), 894-899.
6. Yang, H.; Kao, W.J. Dendrimers for pharmaceutical and biomedical applications. J. Biomater. Sci., Polym. Ed. 2006, 17 (1-2), 3-19.
7. Chan, Y.; Bulmus, V.; Zareie, M.H.; Byrne, F.L.; Barner, L.; Kavallaris, M. Acidcleavable polymeric core-shell particles for delivery of hydrophobic drugs. J. Controlled Rel. 2006, 115 (2), 197-207.
8. Sukhorukov, G.B.; Rogach, A.L.; Zebli, B.; Liedl, T.; Skirtach, A.G.; Koehler, K.; Antipov, A.A.; Gaponik, N.; Susha, A.S.; Winterhalter, M.; Parak, W.J. Nanoengineered polymer capsules: Tools for detection controlled delivery, site-specific manipulation. Small. 2005, 1 (2), 194-200.
9. Osada, K.; Kataoka, K. Drug and gene delivery based on supramolecular assembly of PEG-polypeptide hybrid block copolymers. Adv. Polym. Sci. 2006, 202, (Peptide Hybrid Polymers), 113-153.
10. Jose Alonso, M. Nanomedicines for overcoming biological barriers. Biomed. Pharmacother. 2004, 58 (3), 168-172.
11. Shekunov, B.Y.; Chattopadhyay, P.; Seitzinger, J.; Huff, R. Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions. Pharm. Res. 2006, 23 (1), 196-204.
12. Hasirci, V.; Vrana, E.; Zorlutuna, P.; Ndreu, A.; Yilgor, P.; Basmanav, F.B.; Aydin, E. Nanobiomaterials: A review of the existing science and technology, and new approaches. J. Biomater. Sci. Polym. Ed. 2006, 17 (11), 1241-1268.
13. Meehan, E. Flow injection analysis of polymeric excipients used in pharmaceutical formulations. Int. J. Polym. Anal. Charact. 2006, 11 (1), 35-45.
14. Wyatt, P.J. Light scattering and the absolute characterization of macromolecules. Anal. Chim. Acta. 1993, 272 (1), 1-40.
15. Roduner, E. Size matters: Why nanomaterials are different. Chem. Soc. Rev. 2006, 35 (7), 583-592.
16. Baehr, M.; Führer, C.; Puls, J. Molecular weight distribution, hemicellulose content and batch conformity of pharmaceutical cellulose powders. Eur. J. Pharm. Biopharm. 1991, 37 (3), 136-141.
17. Mun, S.; Xie, Y.; Wang, N.-H. L. Strategies to control batch integrity in sizeexclusion simulated moving bed chromatography. Ind. Eng. Chem. Res. 2005, 44 (9), 3268-3283.
18. Takakura, Y.; Mahato, R.I.; Vishikawa, M.; Hashida, M. Control of pharmacokinetic profiles of drug-macromolecule conjugates. Adv. Drug Delivery Rev. 1996, 19 (3), 377-399.
19. White, G.W.; Katone, T.; Zodda, J.P. The use of high-performance size exclusion chromatography (HPSEC) as a molecular weight screening technique for polygalactouronic acid for use in pharmaceutical applications. J. Pharm. Biomed. Anal. 1999, 20 (6), 905-912.
20. Liu, X.M.; Maziarz, E.P.; Heiler, D.J. Characterization of implant device materials using size-exclusion chromatography with mass spectrometry and with triple detection. J. Chromatogr. A 2004, 1034 (1-2), 125-131.
21. Gref, R.A.; Setzkom, E.A.; Leslie, W.D. A colorimetric method for the determination of parts/million of nonionic surfactants. J. Am. Oil Chem. Soc. 1965, 42 (3), 151-164.
22. Tercyak, A.M.; Felker, T.E. Colorimetric assay for pluronic F-68 as measured in ioslated rat liver perfusion systems. Anal. Biochem. 1990, 187 (1), 54-55.
23. Li, C.; Palmer, W.K.; Johnston, T.P. Disposition of poloxamer 407 in rats following a single intraperitoneal injection assessed using a simplified colorimetric assay. J. Pharm. Biomed. Anal. 1996, 14 (5), 659-665.
24. Ghebeh, H.; Handa-Corrigan, A.; Butler, M. Development of an assay for the measurement of the surfactant pluronic F-68 in mammalian cell culture medium 1998, 262 (1), 39-44.
25. Mao, Y.; Thompson, M.J.; Wang, Q.; Tsai, E.W. Quantitiation of polxamers in pharmaceutical formulations using size exclusion chromatogrpahy and colorimetric methods. J. Pharm. Biomed. Anal. 2004, 35 (5), 1127-1142.
26. Luangtana-Anan, M.; Opanasopit, P.; Ngawhirunpat, T.; Nunthanid, J.; Sriamornsak, P.; Limmatvapirat, S.; Lim, L.Y. Effect of chitosan salts molecular weight on a nanoparticulate carrier for therapeutic protein. Pharm. Dev. Technol. 2005, 10 (2), 189-196.
27. Farrugia, C.A.; Groves, M.J. Gelatin behavior in dilute aqueous solution: Designing a nanoparticulate fomulation. J. Pharm. Pharmacol. 1999, 51 (6), 643-649.
28. Mitra, A.; Lin, S. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems. J. Pharm. Pharmacol. 2003, 55 (7), 895-902.
29. Kallinteri, P.; Higgins, S.; Hutcheon, A.C.; St. Pourcain, C.B.; Garnett, M.C. Novel functionalized biodegradable polymers for nanoparticle drug delivery systems. Biomacromolecules 2005, 6 (4), 1885-1894.
30. Peng, T.; Su, J.; Cheng, S.-X.; Zhou, R.-X. Poly- α,β-(N-(2- hydroxyethyl)-L-aspartamide)-g-poly(1,3-trimethylene carbonate) amphiphilic graft co-polymer as a potential drug carrier. J. Biomater. Sci. Polym. Ed. 2006, 17 (8), 941-951.
31. Sasatsu, M.; Onishi, H.; Machida, Y. Preparation of a PLA-PEG block copolymer using a PLA derivative with a formyl terminal group and its application to nanoparticulate formulation. Int. J. Pharm. 2005, 294 (1-2), 233-245.
32. Fee, C.J. Size-exclusion reaction chromatography (SERC): A new technique for protein PEGylation. Biotechnol. Bioeng. 2003, 82 (2), 200-206.
33. Wabnitz, P.A.; Loo, J.A. Drug screening of pharmaceutical drug discovery compounds by micro-size exclusion chromatography. Rapid Commun. Mass Spectrom. 2002, 16 (2), 85-91.
34. Mendichi, R.; Rizzo, V.; Gigli, M.; Giacometti Schieroni, A. Dilute properties of a polymeric antitumor drug carrier by size-exclusion chromatography, viscometry and light scattering. J. Appl. Polym Sci. 1998, 70 (2), 329-338.
35. Mendichi, R.; Rizzo, V.; Gigli, M.; Giacometti Schieroni, A. Fractionation and characterization of a conjugate between a polymeric drug-carrier and the antitumor drug camptothecin. Bioconjugate. Chem. 2002, 13 (6), 1253-1258.
36. Gabrielle-Madelmont, C.; Lesieur, S.; Ollivon, M. Characterization of loaded liposomes by size exclusion chromatography. J. Biochem. Biophys. Methods 2003, 56 (1-3), 189-217.
37. Lesieur, S.; Gabrielle-Madelmont, C.; Paternostre, M.; Ollivon, M. Study of size distribution and stability of liposomes by high performance gel exclusion chromatography. Chem. Phys. Lipids 1993, 64 (1-3), 57-82.
38. Reber, N.; Spohr, R.; Wolf, A.; Omichi, H.; Tamada, M.; Yoshida, M. Closure characteristics of a thermally responsive single ion-track pore determined by size exclusion method. J. Membr. Sci. 1998, 140 (2), 275-281.
39. Zhu, L.; Seburg, R.A.; Tsai, E.W. Determination of surface-bound hydroxypropylcellulose (HPC) on drug particles in colloidal dispersions using size exclusion chromatography: A comparison of ELS and RI detection. J. Pharm. Biomed. Anal. 2006, 40 (5), 1089-1096.
40. Lemarchand, C.; Gref, R.; Lesieur, S.; Hommel, H.; Vacher, B.; Besheer, A.; Maeder, K.; Couvreur, P. Physico-chemical characterization of polysaccharidecoated nanoparticles. J. Controlled Rel. 2005, 108 (1), 97-111.
41. Juliano, R.L. Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsion. Adv. Drug Del. Rev. 1988, 2 (1), 31-54.
42. Huve, P.; Verrecchia, T.; Bazile, D.; Couvreur, P. Simultaneous use of sizeexclusion chromatography and photon correlation spectroscopy for the characterization of Poly(Lactic Acid) nanoparticles. J. Chromatogr. A 1994, 675 (1-2), 129-139.
43. Steinhauser, I.; Spänkuchm, B.; Strebhardt, K.; Langer, K. Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells. Biomaterials 2006, 27 (28), 4975-4983.
44. 14C]-Poly(DL-lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials 1992, 13 (15), 1093-1102.
45. Seijo, B.; Fattal, E.; Roblot-Treupel, L.; Couvreur, P. Design of nanoparticles of less than 50 nm diameter: Preparation, characterization and drug loading. Int. J. Pharm. 1990, 62 (1), 1-7.
46. Nguyen, L.T.; Wienceck, J.M.; Kirsch, L.E. Characterization methods for the physical stability of biopharmaceuticals. PDA J. Pharm. Sci. Technol. 2003, 57.
47. Jani, P.; Halbert, G.W.; Langridge, J.; Florence, A.T. Nanoparticles uptake by rat gastrointestinal mucosa: Quantitation and particle size dependency. J. Pharm. Pharmacol. 1990, 42 (12), 821-826.
48. Aprahamian, M.; Michel, C.; Humbert, W.; Devissaguet, J.-P.; Damge, C. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol. Cell. 1987, 61 (1-2), 69-76.
49. Landry, F.B.; Bazille, D.V.; Spenlehauer, G.; Veillard, M.; Kreuter, J. Influence of coating agents on the degradation of poly(DL,-lactic acid) nanoparticles in model digestive fluids (USP XXII). S.T.P. Pharm. Sci. 1996, 6 (3), 195-202.
50. Gref, R.; Quellec, P.; Sanchez, A.; Calvo, P.; Dellacherie, E.; Alonso, M.J. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)peg micro- and nanoparticles. comparison with conventional PLA particulate carriers. Eur. J. Pharm. Biopharm. 2001, 51 (2), 111-118.
51. Ismailos, G.; Reppas, C.; Dressman, J.B.; Macheras, P. Unusual solubility behavior of cyclosporin A in aqueous media. J. Pharm. Pharmacol. 1991, 43 (4), 287-289.
52. Taylor, N.E.; Mark, A.E.; Vallat, P.; Brunne, R.M.; Testa, B.; Van Gunteren, W.F. Solvent dependent conformation and hydrogen bonding capacity of cyclosporin A: Evidence from partition coefficinet and molecular dynamics simulations. J. Med. Chem. 1993, 36 (24), 3757-3764.
53. Sautel, M.; Kristulović, A.M. Pharmaceutical analysis beyond compendial requirements. J. Sep. Sci. 2005, 28 (13), 1529-1538.
54. Romero, I.G.; Pasch, H. High-throughput screening of the chemical composition distribution of random styrene-butyl acrylate copolymers. e-Polymers 2005, 42 (1), 1-13.
55. Renn, C.N.; Synovec, R.E. Improved detection in superspeed size-exclusion chromatography by reducing on-column dilution and detector noise. Anal. Chem. 1988, 60 (17), 1829-1832.